Another limitation is the existence of genetic variations in certain genes involved in lipoprotein metabolism that could be related to atherogenesis, such as the FTO gene, which is associated with obesity, insulin resistance, and BMI changes, respectively [69]. The gene discussed is FTO; the disease is Obesity.